Details of Disease
General Information of Disease (ID: DISFW74P)
| Disease Name | Stress urinary incontinence | |||||
|---|---|---|---|---|---|---|
| Synonyms | stress incontinence - female; female urinary stress incontinence | |||||
| Disease Class | MF50: Abnormal micturition | |||||
| Definition | 
                                         
                        The involuntary loss of urine in females secondary to insufficient strength of the pelvic floor muscles; this can result from physical changes following pregnancy and childbirth, or as a response to a decrease in estrogen during menopause.
                        
                     
                                     | 
            |||||
| Disease Hierarchy | ||||||
| ICD Code | 
                    
  | 
            |||||
| Disease Identifiers | ||||||
Drug-Interaction Atlas (DIA) of This Disease
| Drug-Interaction Atlas (DIA) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 
                     This Disease is Treated as An Indication in 1 Approved Drug(s) 
                                                
  | 
            |||||||||||||||||||||||||
| 
                     This Disease is Treated as An Indication in 1 Preclinical Drug(s) 
                                                
  | 
            |||||||||||||||||||||||||
| 
                     This Disease is Treated as An Indication in 1 Discontinued Drug(s) 
                                                
  | 
            |||||||||||||||||||||||||
Molecular Interaction Atlas (MIA) of This Disease
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 
                     This Disease Is Related to 1 DTT Molecule(s) 
                                                
  | 
            |||||||||||||||||||||||||
References
